Patent Assignment
Reel/Frame 044767/0814
Change of Name
Recorded: 2017-11-06
Pages: 3
Assignor
KALOBIOS PHARMACEUTICALS, INC.
Executed: 2017-07-21
Assignee
HUMANIGEN, INC.
1000 MARINA BLVD., SUITE 250, BRISBANE, CALIFORNIA, 94005
Covered Property
(1)
EphA3 Antibodies for the Treatment of Solid Tumors
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →
Security Interest
Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
Release of Security Interest
Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
Security Interest
Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
Release of Security Interest
Jun 12, 2020
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: HUMANIGEN, INC.
Reel/Frame 052920/0631 →